Chronic Kidney Disease Registry Platform Study

Trial Identifier: D1843R00355
Sponsor: AstraZeneca
NCTID:: NCT06117852
Start Date: November 2023
Primary Completion Date: December 2026
Study Completion Date: December 2026
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Beijing, China
China Changsha, China
China Chengdu, China
China Chongqing, China
China Dongguan, China
China Guangzhou, China
China Hengyang, China
China Huaian, China
China Jilin, China
China Nanjing, China
China Nanning, China
China Ningbo, China
China Panjin, China
China Shanghai, China
China Shantou, China
China Shenzhen, China
China Taizhou, China
China Wenzhou, China
China Wuhan, China
China Wuxi, China
China Xi an, China
China Xiamen, China
China Yibin, China
China Zhuzhou, China
China Zigong, China